Next-Gen Tech Company Pops on New Covid Detection Test

Next-Gen Tech Company Pops on New Covid Detection Test

By: Tomas Ronolski - AllPennyStocks.com News

Thursday, June 17, 2021

While the world comes out of the initial stages of the pandemic, Covid-19 will continue to be a threat for some time to come. Companies, such as Zen Graphene, are working on ways to detect the virus and its variants and are on the forefronts of technology. 

Nanotechnology firm ZEN Graphene Solutions Ltd. (TSX-Venture:ZEN) (OTCPK:ZENYF), is working to develop technology to help detect the Covid-19 virus and its variants. The firm signed an exclusive agreement with McMaster University to be the global commercializing partner for a newly developed aptamer-based, SARS-CoV-2 rapid detection technology.

This patent-pending technology uses clinical samples from patients and was funded by the Canadian Institutes of Health Research. The test is considered extremely accurate, scalable, saliva-based, affordable, and provides results in under 10 minutes.

Shares were trading up over 5% to $3.07 in early-afternoon trade.


Copyright © 2021 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Dually-Listed Junior Miner Finds Mid-Week Success
Biotech Soars on Research Collaboration And License Agreement Release
Cannabis Stocks On The Move Amid DEA Reclassification Indication
Most Popular
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top